No insider purchase over the last 90 days. The latest was filed 13 May 2025.
This page follows insider dealings at International Biotechnology Trust plc as filed with RNS (LSE). Between 18 October 2025 and 18 October 2026, 2 insiders published 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
There has been no open-market purchase by an insider of International Biotechnology Trust plc for at least a year. The median gap between a trade and its publication by RNS (LSE) is 1 day. The regulation allows three business days to notify a trade (UK MAR).
Compared with its exchange (833 companies, median 6 filings), a count of 4 filings is below the norm. Looking back to 2023, when coverage begins, insiders filed 7 purchases and no sales.
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended August 2025 · cache
13 of 13 declarations
International Biotechnology Trust plc is an investment company focused on the biotechnology sector. It aims to provide investors with exposure to innovative companies in this field.